AstraZeneca PLC (AZN) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
A high-level overview of AstraZeneca PLC (AZNCF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN) : Free Stock Analysis Report Arcturus Therapeutics Holdings Inc. (ARCT) : Free Stock Analysis Report Fulcrum Therapeutics, Inc. (FULC) : Free Stock Analysis Report Bioventus Inc...
Peer analysis Key Information CompanyRevenue (TTM)Net income (TTM)Market capEmployees Gilead Sciences Inc23.18bn103.21m91.75bn18.00k Bristol-Myers Squibb Co38.85bn-5.95bn92.75bn34.10k Sanofi SA41.00bn3.78bn101.35bn87.99k Amgen Inc26.65bn3.46bn115.46bn26.70k ...
AstraZeneca's Oncology Success: Fueling Future GrowthALLKA ResearchTue, Jun. 25, 20245 Comments AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade)Manika PremsinghSat, Jun. 15, 20247 Comments Share your Analysis on AZNSubmit an article now See All Analysis » AZN News ...
Share Company page Our story Webcasts Trade recap Fundamentals Analysis EquityWhat's this? Price (GBX)11,344.00 0.27% (30.00)AZNORD SHS $0.25 Track 6 more instruments Open / Last close11,422.00 / 11,344.00 High / Low11,438.00 / 11,314.00 ...
But I think that had we shown the results that we did in a statistical analysis, those would have been statistically significant and clinically meaningful and I think that we've applied the lessons from that into the front line. So I think that's an important piece. And I think that ...
(See AstraZeneca stock analysis on TipRanks). That’s with a Strong Buy consensus rating backed by 6 Buy ratings versus only 1 Hold rating. What’s more, the average analyst price target stands at $67.50, which puts the upside potential at a promising 33% in the coming 12 ...
---,AstraZeneca PLC: Labor Productivity Benchmarks and International Gap Analysis,San Diego: Icon Group International, Incorporated, October, 2000. Jarvis, Lisa, "AstraZeneca Introduces Next Generation Prilosec,"Chemical Market Reporter, September 18, 2000, pp. 5, 12. Jury,...
AstraZeneca PLC Company Current Valuation Analysis AstraZeneca PLC's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account ...